Article

Combined immunodeficiency associated with DOCK8 mutations.

Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
New England Journal of Medicine (Impact Factor: 54.42). 09/2009; 361(21):2046-55. DOI: 10.1056/NEJMoa0905506
Source: PubMed

ABSTRACT Recurrent sinopulmonary and cutaneous viral infections with elevated serum levels of IgE are features of some variants of combined immunodeficiency. The genetic causes of these variants are unknown.
We collected longitudinal clinical data on 11 patients from eight families who had recurrent sinopulmonary and cutaneous viral infections. We performed comparative genomic hybridization arrays and targeted gene sequencing. Variants with predicted loss-of-expression mutations were confirmed by means of a quantitative reverse-transcriptase-polymerase-chain-reaction assay and immunoblotting. We evaluated the number and function of lymphocytes with the use of in vitro assays and flow cytometry.
Patients had recurrent otitis media, sinusitis, and pneumonias; recurrent Staphylococcus aureus skin infections with otitis externa; recurrent, severe herpes simplex virus or herpes zoster infections; extensive and persistent infections with molluscum contagiosum; and human papillomavirus infections. Most patients had severe atopy with anaphylaxis; several had squamous-cell carcinomas, and one had T-cell lymphoma-leukemia. Elevated serum IgE levels, hypereosinophilia, low numbers of T cells and B cells, low serum IgM levels, and variable IgG antibody responses were common. Expansion in vitro of activated CD8 T cells was impaired. Novel homozygous or compound heterozygous deletions and point mutations in the gene encoding the dedicator of cytokinesis 8 protein (DOCK8) led to the absence of DOCK8 protein in lymphocytes.
Autosomal recessive DOCK8 deficiency is associated with a novel variant of combined immunodeficiency.

Download full-text

Full-text

Available from: Amanda Favreau, Aug 25, 2014
1 Follower
 · 
171 Views
  • Source
    • "Homozygous FREM1 gene frameshift and missense mutations were associated with bifid nose, anorectal and renal anomalies (BNAR [OMIM 608980]) (Alazami et al., 2009), and our patient presented three superior oral frenula and genital anomalies similar to BNAR patients. Also localized in the critical subtelomeric region of 9p (9p24) is the DOCK8 gene that has been associated to the autosomal recessive Hyper-IgE Recurrent Infection Syndrome, since DOCK8 mutations have been described in patients with recurrent infections , atopic dermatitis, and food and environmental allergies (Zhang et al., 2009). The loss of DOCK8 heterozygosity might be responsible for the recurrent infections observed in 9p deletion syndrome patients like ours. "
    [Show abstract] [Hide abstract]
    ABSTRACT: We describe a female patient with developmental delay, dysmorphic features and multiple congenital anomalies who presented a normal G-banded karyotype at the 550-band resolution. Array and multiplex-ligation probe amplification (MLPA) techniques identified an unexpected large unbalanced genomic aberration: a 17.6Mb deletion of 9p associated to a 14.8 Mb duplication of 20p. The deleted 9p genes, especially CER1 and FREM1, seem to be more relevant to the phenotype than the duplicated 20p genes. This study also shows the relevance of using molecular techniques to make an accurate diagnosis in patients with dysmorphic features and multiple anomalies suggestive of chromosome aberration, even if on G-banding their karyotype appears to be normal. Fluorescence in situ hybridization (FISH) was necessary to identify a masked balanced translocation in the patient's mother, indicating the importance of associating cytogenetic and molecular techniques in clinical genetics, given the implications for patient management and genetic counseling.
    Gene 03/2012; 496(1):59-62. DOI:10.1016/j.gene.2012.01.007 · 2.08 Impact Factor
  • Source
    • "March 2012 | Volume 3 | Article 37 | 7 1999). Hence, primary immune deficiencies with defective quality of signal 1, such as Wiskott-Aldrich syndrome and DOCK8 immunodeficiency patients, share clinical characteristics (e.g., eczema, elevated IgE levels, cutaneous M. contagiosum or Papilloma and Herpes viral infections, and increased tumor incidence (Bosticardo et al., 2009; Zhang et al., 2009). Both Dock8 and WAS protein are important for T cell synapse formation (Dupre et al., 2002; Randall et al., 2011), and crucial for interactions between naive CD8 + T cells and DC (Pulecio et al., 2008; Randall et al., 2011). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Cross-presentation of endocytosed antigen as peptide/class I major histocompatibility complex complexes plays a central role in the elicitation of CD8(+) T cell clones that mediate anti-viral and anti-tumor immune responses. While it has been clear that there are specific subsets of professional antigen presenting cells capable of antigen cross-presentation, identification of mechanisms involved is still ongoing. Especially amongst dendritic cells (DC), there are specialized subsets that are highly proficient at antigen cross-presentation. We here present a focused survey on the cell biological processes in the endosomal pathway that support antigen cross-presentation. This review highlights DC-intrinsic mechanisms that facilitate the cross-presentation of endocytosed antigen, including receptor-mediated uptake, maturation-induced endosomal sorting of membrane proteins, dynamic remodeling of endosomal structures and cell surface-directed endosomal trafficking. We will conclude with the description of pathogen-induced deviation of endosomal processing, and discuss how immune evasion strategies pertaining endosomal trafficking may preclude antigen cross-presentation.
    Frontiers in Immunology 03/2012; 3:37. DOI:10.3389/fimmu.2012.00037
  • Source
    • "Besides Bcl6, deficiency in other GC-related molecules results in higher production of IgE. Deficiency of dedicator of cytokinesis 8 (Dock8) caused unstable germinal centers in mice (Randall et al., 2009) and hyper-IgE syndrome (HIES) in humans (Engelhardt et al., 2009; Zhang et al., 2009). IL-21 is a critical cytokine produced by T FH cells; similarly to Bcl6 and Dock8, IL-21R-deficient mice have higher IgE and lower IgG1 level (Ozaki et al., 2002). "
    [Show abstract] [Hide abstract]
    ABSTRACT: IgE antibodies are involved in allergic reactions. High affinity IgE antibodies can cause anaphylaxis when cross-linked by minute amounts of antigen. The issue of how the IgE response is initiated and maintained is addressed in this review. A model has been proposed by which IgE(+) cells expressing antibodies that bind with high affinity to their antigens are generated through an IgG1 intermediate, which goes through affinity maturation in germinal centers (GC) before undergoing sequential switching to IgE. Mice deficient in IgG1 produce IgE at almost normal levels, but the IgE antibodies produced in IgG1-deficient mice lack the antigen-binding strength and the somatic mutations associated with affinity maturation. A GFP reporter strain, which expresses a modified IgE molecule, was recently developed and was utilized to challenge the sequential switching model. Several molecules that are highly expressed in GC can antagonize class switching to IgE in GC antagonize partially class switching to IgE; in addition, GC IgE(+) cells are gradually lost from GC as the immune response progresses, as shown with another recently developed, Venus-expressing IgE reporter mouse strain. In contrast, as a population, IgG1 cells thrive in the GC environment. Membrane IgE-expressing plasmablasts and plasma cells (PC) were recognized as a major component of the IgE response in secondary lymphoid organs. The swift development of IgE cells toward the PC fate, together with the affinity maturation of the IgE response via an IgG intermediate, represent the most salient features of the IgE immune responses, which make them distinct from IgG responses.
    Advances in Immunology 01/2012; 116:113-41. DOI:10.1016/B978-0-12-394300-2.00004-1 · 5.53 Impact Factor
Show more